Bayer Aktiengesellschaft (BAYRY) Q3 2026 Earnings Call Transcript

What happened: Bayer reported third quarter 2026 results, with CEO William Anderson saying the company is on track to meet its commitments nine months into the year and is upgrading its outlook in several areas. Key numbers: Sales grew 3% organically. Core EPS was EUR 3.97. Free cash flow was negative EUR 3 billion due to known litigation-related payments. Why it matters: Management cited operational resilience and said Crop Science and Consumer Health are performing in line with targets, while Pharma growth is led by Nubeqa and Kerendia.

Bayer reported third quarter 2026 results, with CEO William Anderson saying the company is on track to meet its commitments nine months into the year and is upgrading its outlook in several areas.

Management cited operational resilience and said Crop Science and Consumer Health are performing in line with targets, while Pharma growth is led by Nubeqa and Kerendia.